Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.
T cells from ART-suppressed individuals can originate from biologically competent proviruses.
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective study.
Pitting of malaria parasites in microfluidic devices mimicking spleen interendothelial slits.
A summary of the sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment.
Farmacogenética y Farmacogenómica.Microbioma intestinal